Jump menu

Main content |  back to top

News and Media Releases

SNEPCo boosts medical training at UNILAG with donation of audio-visual studio

Training of doctors has been made much easier at the College of Medicine, University of Lagos, thanks to the provision of an ultra-modern audio-visual studio by Shell Nigeria Exploration and Production Company Ltd (SNEPCo). The studio will be used to record lectures and helps to provide a more learning friendly platform, making it easier for students to access information around the world.
Sound Engineer, University of Lagos, Dr. Alabi, explaining the functions of the new ultra-modern medical audiovisual equipment.

Sound Engineer, University of Lagos, Dr. Alabi, explaining the functions of the new ultra-modern medical audiovisual equipment.

“The project is another demonstration of our commitment to quality education,” said SNEPCo’s Business Relations Manager, Ijere Kanu, as he represented the Managing Director of the company, Tony Attah at the commissioning of the facility on February 5. “It is our tradition in SNEPCo to ensure that Nigerians – individuals and institutions – benefit from our presence, and together with our partners, we will continue to expand opportunities for students across Nigeria as part of our broader corporate sustainability programmes.”

In an address he sent to the occasion, Group General Manager, NAPIMS, Engr, Jonathan Okehs said: “We will continue to support projects that will affect the lives and future of the citizens of Nigeria positively just as the audio-visual studio we’re commissioning.”

A major goal in medical education is to improve teamwork and the love for lifelong learning. And research has shown that students cannot only learn by reading but also by audio-visual where they can interact and engage in intellectual discussions. This is where we need an ultra-modern audio-visual studio and we are grateful to SNEPCo and NAPIMS for helping to bring our dream to fruition.

The Provost of College of Medicine, University of Lagos, Prof. Folashade Ogunshola

SNEPCo’s donation involves the provision of soundproof padding, high quality video and audio recorders, editing hardware and software, monitor, wireless microphones, speakers, air conditioners and general studio furniture. SNEPCo also awards scholarships to Nigerian undergraduate and postgraduate students, and provides entrepreneurial and skill-acquisition to promote self-employment among youths.

The College of Medicine at the University of Lagos has produced over 7000 medical, dental and allied health professionals in over 50 years of existence.

Issued by: Precious Okolobo

Corporate Media Relations Manager

+234 8070365019

February 09, 2015.

Cautionary statement:

The companies in which Royal Dutch Shell plc directly and indirectly owns investments are separate entities. In this press release “Shell”, “Shell group” and “Royal Dutch Shell” are sometimes used for convenience where references are made to Royal Dutch Shell plc and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this presentation refer to companies over which Royal Dutch Shell plc  either directly or indirectly has control. Companies over which Shell has joint control are generally referred to “joint ventures” and companies over which Shell has significant influence but neither control nor joint control are referred to as “associates”. In this press release, joint ventures and associates may also be referred to as “equity-accounted investments”. The term “Shell interest” is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in a venture, partnership or company, after exclusion of all third-party interest.

This presentation contains forward-looking statements concerning the financial condition, results of operations and businesses of Royal Dutch Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Royal Dutch Shell to market risks and statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’, ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. There are a number of factors that could affect the future operations of Royal Dutch Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this presentation, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell’s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; and (m) changes in trading conditions. All forward-looking statements contained in this presentation are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Royal Dutch Shell’s 20-F for the year ended December 31, 2014 (available at www.shell.com/investor and www.sec.gov ). These risk factors also expressly qualify all forward looking statements contained in this presentation and should be considered by the reader.  Each forward-looking statement speaks only as of the date of press release, February 09, 2015.Neither Royal Dutch Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this presentation.

We may have used certain terms, such as resources, in this presentation that United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC.  U.S. Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website www.sec.gov. You can also obtain these forms from the SEC by calling 1-800-SEC-0330.